Global Healthcare Reit Stock Alpha and Beta Analysis
| GBCS Stock | USD 1.70 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Global Healthcare REIT. It also helps investors analyze the systematic and unsystematic risks associated with investing in Global Healthcare over a specified time horizon. Remember, high Global Healthcare's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Global Healthcare's market risk premium analysis include:
Beta 1.11 | Alpha (0.22) | Risk 6.06 | Sharpe Ratio (0.01) | Expected Return (0.07) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Global |
Global Healthcare Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Global Healthcare market risk premium is the additional return an investor will receive from holding Global Healthcare long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Global Healthcare. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Global Healthcare's performance over market.| α | -0.22 | β | 1.11 |
Global Healthcare expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Global Healthcare's Buy-and-hold return. Our buy-and-hold chart shows how Global Healthcare performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Global Healthcare Market Price Analysis
Market price analysis indicators help investors to evaluate how Global Healthcare pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Global Healthcare shares will generate the highest return on investment. By understating and applying Global Healthcare pink sheet market price indicators, traders can identify Global Healthcare position entry and exit signals to maximize returns.
Global Healthcare Return and Market Media
The median price of Global Healthcare for the period between Tue, Sep 3, 2024 and Mon, Dec 2, 2024 is 1.7 with a coefficient of variation of 13.24. The daily time series for the period is distributed with a sample standard deviation of 0.22, arithmetic mean of 1.69, and mean deviation of 0.18. The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Global Healthcare Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Global or other pink sheets. Alpha measures the amount that position in Global Healthcare REIT has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Global Healthcare Upcoming Company Events
As portrayed in its financial statements, the presentation of Global Healthcare's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Global Healthcare's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Global Healthcare's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Global Healthcare. Please utilize our Beneish M Score to check the likelihood of Global Healthcare's management manipulating its earnings.
| 4th of July 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Global Healthcare
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Global Pink Sheet Analysis
When running Global Healthcare's price analysis, check to measure Global Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Healthcare is operating at the current time. Most of Global Healthcare's value examination focuses on studying past and present price action to predict the probability of Global Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Healthcare's price. Additionally, you may evaluate how the addition of Global Healthcare to your portfolios can decrease your overall portfolio volatility.